These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23630431)
1. Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain? Kern KU; Nalamachu S; Brasseur L; Zakrzewska JM J Pain Res; 2013; 6():261-80. PubMed ID: 23630431 [TBL] [Abstract][Full Text] [Related]
2. Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma. Nicolaou A; Nicholson B; Hans G; Brasseur L J Pain Res; 2011 Jan; 4():25-38. PubMed ID: 21386952 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937 [TBL] [Abstract][Full Text] [Related]
4. Topical pain management with the 5% lidocaine medicated plaster--a review. Mick G; Correa-Illanes G Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108 [TBL] [Abstract][Full Text] [Related]
6. Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster - a case series. Likar R; Demschar S; Kager I; Neuwersch S; Pipam W; Sittl R Int J Gen Med; 2015; 8():9-14. PubMed ID: 25565882 [TBL] [Abstract][Full Text] [Related]
7. Lidocaine 700 mg medicated plaster for postherpetic neuralgia: real-world data from the German Pain e-Registry. Überall MA; Eerdekens M; Hollanders E; Bösl I; Sabatschus I Pain Manag; 2022 Mar; 12(2):195-209. PubMed ID: 34372662 [TBL] [Abstract][Full Text] [Related]
8. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. de León-Casasola OA; Mayoral V J Pain Res; 2016; 9():67-79. PubMed ID: 26929664 [TBL] [Abstract][Full Text] [Related]
10. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499 [TBL] [Abstract][Full Text] [Related]
11. Treatment of neuropathic pain with 5% lidocaine-medicated plaster: Five years of clinical experience. Delorme C; Navez ML; Legout V; Deleens R; Moyse D Pain Res Manag; 2011; 16(4):259-63. PubMed ID: 22059196 [TBL] [Abstract][Full Text] [Related]
12. Postsurgical neuropathic pain: lidocaine 700 mg medicated plaster or oral treatments in clinical practice. A Überall M; Bösl I; Hollanders E; Sabatschus I; Eerdekens M Pain Manag; 2022 Sep; 12(6):725-735. PubMed ID: 35713406 [TBL] [Abstract][Full Text] [Related]
13. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain]. Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960 [TBL] [Abstract][Full Text] [Related]
14. The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use. Baron R; Allegri M; Correa-Illanes G; Hans G; Serpell M; Mick G; Mayoral V Pain Ther; 2016 Dec; 5(2):149-169. PubMed ID: 27822619 [TBL] [Abstract][Full Text] [Related]
15. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723 [TBL] [Abstract][Full Text] [Related]
16. Comparative Benefit-Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach. Sabatschus I; Bösl I; Prevoo M; Eerdekens M; Sprünken A; Galm O; Forstner M Pain Ther; 2022 Mar; 11(1):73-91. PubMed ID: 34792789 [TBL] [Abstract][Full Text] [Related]
17. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial. Palladini M; Boesl I; Koenig S; Buchheister B; Attal N Curr Med Res Opin; 2019 May; 35(5):757-766. PubMed ID: 30614286 [TBL] [Abstract][Full Text] [Related]
18. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France. Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735 [TBL] [Abstract][Full Text] [Related]
19. Lidocaine 5%-medicated plaster (Versatis) for localised neuropathic pain: results of a multicentre evaluation of use in children and adolescents. Goddard JM; Reaney RL Br J Pain; 2018 Aug; 12(3):189-193. PubMed ID: 30057764 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the topical 5% lidocaine medicated plaster in the treatment of chronic post-thoracotomy neuropathic pain. Sansone P; Passavanti MB; Fiorelli A; Aurilio C; Colella U; De Nardis L; Donatiello V; Pota V; Pace MC Pain Manag; 2017 May; 7(3):189-196. PubMed ID: 28326950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]